A detailed history of American International Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 68,341 shares of TGTX stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,341
Previous 68,928 0.85%
Holding current value
$1.22 Million
Previous $1.18 Million 11.72%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.02 - $21.3 $7,642 - $12,503
-587 Reduced 0.85%
68,341 $1.04 Million
Q4 2023

Feb 13, 2024

BUY
$6.68 - $18.81 $2,979 - $8,389
446 Added 0.65%
68,928 $1.18 Million
Q3 2023

Nov 13, 2023

BUY
$8.36 - $26.5 $20,356 - $64,527
2,435 Added 3.69%
68,482 $572,000
Q2 2023

Aug 04, 2023

BUY
$15.48 - $35.0 $27,229 - $61,565
1,759 Added 2.74%
66,047 $1.64 Million
Q1 2023

May 12, 2023

BUY
$10.23 - $19.34 $13,084 - $24,735
1,279 Added 2.03%
64,288 $966,000
Q4 2022

Feb 10, 2023

SELL
$5.01 - $11.83 $1,147 - $2,709
-229 Reduced 0.36%
63,009 $745,000
Q3 2022

Nov 14, 2022

BUY
$4.57 - $8.4 $4,081 - $7,501
893 Added 1.43%
63,238 $374,000
Q2 2022

Aug 12, 2022

SELL
$3.74 - $10.66 $7,337 - $20,914
-1,962 Reduced 3.05%
62,345 $265,000
Q1 2022

May 13, 2022

SELL
$7.81 - $20.45 $35,355 - $92,577
-4,527 Reduced 6.58%
64,307 $612,000
Q4 2021

Feb 11, 2022

SELL
$15.2 - $35.51 $20,170 - $47,121
-1,327 Reduced 1.89%
68,834 $1.31 Million
Q3 2021

Nov 12, 2021

SELL
$21.78 - $40.45 $36,307 - $67,430
-1,667 Reduced 2.32%
70,161 $2.34 Million
Q2 2021

Aug 13, 2021

SELL
$32.5 - $48.96 $73,027 - $110,013
-2,247 Reduced 3.03%
71,828 $2.79 Million
Q1 2021

May 07, 2021

BUY
$41.61 - $54.3 $144,345 - $188,366
3,469 Added 4.91%
74,075 $3.57 Million
Q4 2020

Feb 12, 2021

BUY
$25.27 - $54.9 $106,285 - $230,909
4,206 Added 6.33%
70,606 $3.67 Million
Q3 2020

Nov 04, 2020

BUY
$18.49 - $27.24 $135,513 - $199,641
7,329 Added 12.41%
66,400 $1.78 Million
Q2 2020

Aug 12, 2020

BUY
$8.9 - $21.84 $71,707 - $175,964
8,057 Added 15.79%
59,071 $1.15 Million
Q1 2020

May 04, 2020

SELL
$7.14 - $15.99 $21,041 - $47,122
-2,947 Reduced 5.46%
51,014 $502,000
Q4 2019

Feb 05, 2020

BUY
$5.1 - $11.2 $11,072 - $24,315
2,171 Added 4.19%
53,961 $599,000
Q3 2019

Nov 08, 2019

BUY
$5.38 - $8.99 $9,678 - $16,173
1,799 Added 3.6%
51,790 $291,000
Q2 2019

Aug 13, 2019

BUY
$6.27 - $8.65 $62,323 - $85,981
9,940 Added 24.82%
49,991 $432,000
Q1 2019

May 06, 2019

SELL
$4.02 - $8.04 $5,221 - $10,443
-1,299 Reduced 3.14%
40,051 $322,000
Q4 2018

Feb 13, 2019

SELL
$3.44 - $5.76 $1,090 - $1,825
-317 Reduced 0.76%
41,350 $170,000
Q3 2018

Nov 09, 2018

BUY
$5.15 - $14.0 $16,098 - $43,764
3,126 Added 8.11%
41,667 $233,000
Q2 2018

Aug 08, 2018

BUY
$12.5 - $15.0 $71,475 - $85,770
5,718 Added 17.42%
38,541 $507,000
Q1 2018

May 07, 2018

SELL
$8.7 - $16.8 $15,355 - $29,652
-1,765 Reduced 5.1%
32,823 $466,000
Q4 2017

Feb 09, 2018

BUY
$7.35 - $12.3 $15,089 - $25,251
2,053 Added 6.31%
34,588 $284,000
Q3 2017

Nov 09, 2017

BUY
$10.0 - $12.7 $325,350 - $413,194
32,535
32,535 $386,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $2.58B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.